BioPharmSignal logoBioPharmSignal

Biotech News

Veradigm Files 2023 and 2024 Form 10-K

Veradigm (MDRX)VeradigmSEC filing

Reaches Major SEC Filing Milestone; Now Advancing 2025 and 2026 Filings CHICAGO --(BUSINESS WIRE)--May 26, 2026-- Veradigm ® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today the filing of its comprehensive Annual Report on

Related news

MDRXVeradigm2026-05-26 12:01 EST

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

MDRXVeradigm2026-02-17 21:01 EST

Veradigm Provides Business and Strategy Update

View all latest news

Veradigm

Veradigm is a healthcare information and analytics company focused on software, data, and workflow tools for providers and life-sciences customers. Its business is more about information infrastructure than therapeutic innovation.

Recent company news

MDRXVeradigm2026-05-26 20:10 EST

Veradigm Files 2023 and 2024 Form 10-K

MDRXVeradigm2026-05-26 12:01 EST

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

MDRXVeradigm2026-05-06 20:01 EST

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

MDRXVeradigm2026-05-06 12:01 EST

Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

MDRXVeradigm2026-04-28 20:01 EST

Veradigm Receives KLAS 2026 Points of Light Award for Embedding SDOH Data in Provider EHR Workflows

Stock data

Close
4.80 USD
Market cap
—
Exchange
NASDAQ
Sector
Biopharma
Location
United States